ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

OFK Orion Corporation

37.73
0.709999 (1.92%)
31 May 2024 - Closed
Realtime Data
Share Name Share Symbol Market Type
Orion Corporation TG:OFK Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.709999 1.92% 37.73 37.66 37.80 37.30 37.19 37.19 20 22:50:06

Orion Corporation: Managers’ transactions – Ari Lehtoranta

06/05/2024 10:00am

GlobeNewswire Inc.


Orion (TG:OFK)
Historical Stock Chart


From May 2024 to Jun 2024

Click Here for more Orion Charts.
Orion Corporation: Managers’ transactions – Ari Lehtoranta

ORION CORPORATION MANAGERS’ TRANSACTIONS 6 MAY 2024 at 12.00 EEST        

Orion Corporation: Managers’ transactions – Ari Lehtoranta

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Orion Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Ari LehtorantaPosition: Member of the Board/Deputy memberIssuer: Orion OyjLEI: 74370029VAHCXDR7B745Notification type: INITIAL NOTIFICATIONReference number: 61582/4/4

____________________________________________Transaction date: 2024-05-03Outside a trading venueInstrument type: SHAREISIN: FI0009014377Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE

Transaction details(1): Volume: 678 Unit price: 0 EUR

Aggregated transactions (1): Volume: 678 Volume weighted average price: 0 EUR

Orion Corporation

Liisa HurmePresident and CEO   Olli HuotariSVP, Corporate Functions 

                                                

Publisher:Orion CorporationCommunicationsOrionintie 1A, FI-02200 Espoo, Finlandhttp://www.orion.fi/enhttp://www.twitter.com/OrionCorpIR

Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion's net sales in 2023 amounted to EUR 1,190 million and the company had about 3,600 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.

1 Year Orion Chart

1 Year Orion Chart

1 Month Orion Chart

1 Month Orion Chart

Your Recent History

Delayed Upgrade Clock